Neurology® Podcast

1) MRI sign of progressive supranuclear palsy and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Luke Massey about his paper on an MRI sign of progressive supranuclear palsy. Dr. Roy Strowd is reading our e-Pearl of the week about the hummingbird sign. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about late treatment of motor symptoms. The participants had nothing to disclose except Drs. Morgan, Massey and Strowd.Dr. Morgan is a consultant for Impax Laboratories, Inc. and Veloxis Pharmaceuticals; serves on the speakers' bureaus of GlaxoSmithKline, Teva Pharmaceuticals Industries Ltd., UCB and GE Healthcare; performed CME for Oakstone Publishing, LLC; receives research support from the NIH and received compensation for review of medical records and expert witness testimony in multiple cases of litigation involving neurologic conditions.Dr. Massey received research support from the PSP Association Europe.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.

1) Diagnosis of gluten ataxia and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Barrett interviews Dr. Marios Hadjivassiliou about his paper on the diagnosis of gluten ataxia. Dr. Roy Strowd is reading our e-Pearl of the week about tonic spasms in multiple sclerosis. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about early treatment of motor symptoms. The participants had nothing to disclose except Dr. Strowd.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.

Immune mediated, toxic & infectious ataxias

1) Exposure to stroke belt on incident stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Virginia Howard about her paper on exposure to the stroke belt on incident stroke in adulthood. Dr. Adam Numis is reading our e-Pearl of the week about Neuro-Behcet's disease. In the next part of the podcast Dr. Brett Kissela focuses his interview with Dr. Chelsea Kidwell about the MR Rescue trial. The participants had nothing to disclose except Drs Howard, Numis, Kissela and Kidwell.Dr. Howard serves on DSMB for NIH-NIDA; is a consultant for NIH review committees and receives research support from the NIH.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.Dr. Kidwell serves as an editorial board member of Stroke, Neurocritical Care Journal, Journal of Neuroimaging and Stroke Research and Treatment; and receives research support from Baxter and NIH.

1) Atrial fibrillation and unexplained stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Bryan Eckerle interviews Dr. Paul Cotter about his paper on incidence of atrial fibrillation and unexplained stroke. Dr. Adam Numis is reading our e-Pearl of the week about LGI-1 antibodies in limbic encephalitis. In the next part of the podcast Dr. Brett Kissela interviews Drs. Opeolu Adeoye and Art Pancioli about the CLEAR-ER trial. The participants had nothing to disclose except Drs Cotter, Numis, Kissela and Adeoye.Dr. Cotter receives research support from the UK National Institute for Health Research, Cambridge biomedical Research Center and Clinical Research Fellowship.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.Dr. Adeoye received honoraria for serving on the speakers' bureau of Genentech, Inc. and receives research support from the NIH.

1) Human herpes 6 virus encephalitis and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Jen interviews Dr. Mina Bhanushali and Sarah Kranick about their paper on human herpes 6 virus encephalitis and stem cell transplantation. Dr. Adam Numis is reading our e-Pearl of the week about ictal syncope. In the next part of the podcast Dr. Brett Kissela interviews Dr. Clay Johnston about CHANCE trial. All the participants have disclosures.Dr. Jen serves as an Associate Editor of Frontiers in Neuro-otology and Section Editor of Experimental Brain Research and receives research support from the FDA.Ms. Kranick is a staff member of the National Institute of Health.Dr. Bhanushali Is an employee of the National Institute of Health.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.Dr. Johnston serves as Co-Editor-in-Chief of Journal Watch Neurology; serves as Vice Editor of Annals of Neurology; is co-holder of patent on the RNA panel to identify TIA and risk stratify; Stryker Neurovascular, Boston Scientific, Kaiser-Permanente, NCRR/NCATS, CTSA, AHA/ASA, Bugher Award and the NIH and provided expert testimony in legal proceedings for GlaxoSmithKline.

1) PML diagnostic criteria: Consensus statement from AAN Neuroinfectious Disease Section and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joseph Berger about the consensus paper from the PML Guidelines Committee of the AAN Neuroinfectious Disease Section. Dr. Andy Numis is reading our e-Pearl of the week about spinal epidural abscesses. In the next part of the podcast Dr. Brett Kissela interviews Dr. Marc Chimowitz about SAMMPRIS trial. The participants had nothing to disclose except Drs. Berger, Numis, Kissela and Chimowitz.Dr. Berger serves as an Associate Editor for the Journal of Neurovirology, serves as an editorial board member of ISRN Education, Neuroscience, World Journal of Rheumatology and MS and other related disorders; serves on the PML adjudication committees of Millenium/Takeda and Amgen; has served as a consultant to Millennium/Takeda, Amgen, Genzyme, Eisai and Novartis; and receives honoraria from Genzyme. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.Dr. Chimowitz serves as an editorial board member for the journals Stroke and Neurosurgery; has received grant support from NIH/ NINDS to lead multicenter trials on the treatment of intracranial arterial stenosis; for these NIH funded trials, he has also received research support from Stryker Corporation (donation of intracranial stents, payments for 3rd party monitoring of trial), AstraZeneca Corporation (donation of statin), Bayer (donation of aspirin and placebo) and Bristol Myers Squibb (donation of warfarin and placebo); serves on the data safety monitoring board for an industry funded PFO closure study sponsored by Gore Corporation and on a stroke event adjudication panel for an osteoporosis trial funded by Merck and has also provided medico-legal reviews on stroke related cases.

1) NMO spectrum and MS brain lesion and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Lucy Matthews about her paper on seropositive NMO spectrum disorder and MS brain lesion distribution. Dr. Adam Numis is reading our e-Pearl of the week about intravascular B-cell lymphoma. In the next part of the podcast Dr. Brett Kissela interviews Dr. Joseph Broderick about IMS III trial. All the participants have disclosures.Dr. Keegan serves as Chief Editor for eMedicine; is a consultant for Bionest and Novartis. Dr. Matthews receives research support from UK Medical Research Council and is funded by the Clinical Research Training Fellow ship.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.Dr. Broderick has served as a consultant for PhotoThera-DSMB for NEST III study and Genentech, Inc.; receives funding for travel to NIH study section and NIH-sponsored meetings, TST meeting and national meeting by Covidien and RISS Summit by Genentech and as part as invited Visiting Professor; has received research support from Boehringer Ingelheim, Concentric, EKOS, Genentech, Inc, Johnson & Johnson, Novo Nordisk, Schering-Plough Corp, Merck, and the NIH as part of NINDS funded clinical trials.

Encephalopathies caused by drugs, vitamins, infectious and autoimmune disorders

1) Preclinical Alzheimer disease and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Prof. Michael Ewers about his paper on preclinical Alzheimer disease. Dr. Stacey Clardy is reading our e-Pearl of the week about neurologic symptoms in relapsing polychondritis. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias and sporadic, degenerative ataxias. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs Jeff Burns, Ewers, Clardy, Ted Burns, Perlman and Schmahmann.Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International and receives research support from the NIH, Alzheimer's Drug Discovery Foundation, Elan, Janssen Pharmaceuticals Inc., Wyeth, Pfizer Inc, Novartis Pharmaceuticals Ltd, Danone, Avid Radiopharmaceuticals, Merck Serono and for clinical trials.Dr. Ewers serves as Senior Editor of Alzheimer's & Dementia and receives compensation for traveling to conferences from the Alzheimer's Association and International College of Geriatric Psychoneuropharmacology.Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

1) Niemann-Pick type C and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Matthis Synofzik about his paper on Niemann-Pick type C. Dr. Stacey Clardy is reading our e-Pearl of the week about cephalic tetanus. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias. The participants had nothing to disclose except Drs Burns, Synofzik, Clardy, Perlman and Schmahmann.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Synofzik receives honoraria from Actelion Pharmaceuticals; receives travel funding from Movement Disorders Society and receives research support from the Volkswagen Foundation.Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

1) Pitfalls in electronic health records and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mike Brogan interviews Dr. Jim Bernat about his paper on pitfalls in electronic health records. Dr. Stacey Clardy is reading our e-Pearl of the week about Aicardi-Goutieres syndrome. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of other acquired cerebellar ataxias. The participants had nothing to disclose except Drs Bernat, Clardy, Burns, Perlman and Schmahmann.Dr. Bernat serves as an editorial board member of Neurocritical Care, Neurology Today and Multiple Sclerosis and Related Diseases, receives compensation for serving on the editorial board of The Physician's Index for Ethics and Medicine and receives royalties from the publication of the book Ethical issues in Neurology.Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

1) Intravenous thrombolysis and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Dr. Henrik Gensicke about his paper on stroke patients treated with intravenous thrombolysis. Dr. Stacey Clardy is reading our e-Pearl of the week about brachial plexopathy. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of immune-mediated cerebellar ataxias. The participants had nothing to disclose except Drs Kissela, Gensicke, Clardy, Burns, Perlman and Schmahmann.Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.Dr. Gensicke receives research support from the Swiss National Science Foundation.Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

Encephalopathies caused by endocrine, electrolyte and organ dysfunction

1) Spinal ischemic stroke and 2) Topic of the month: Child neurology topics. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Pearce Korb interviews Dr. Ronen Leker about his paper on spinal ischemic stroke following dialysis. Dr. Chafic Karam is reading our e-Pearl of the week about adrenomyeloneuropathy. In the next part of the podcast Dr. Jeff Waugh interviews Dr. Jonathan Mink about the topic of pediatric movement disorders. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Leker, Karam and Mink.Dr. Leker serves as an editorial board member of Journal of Molecular Neuroscience, Current Neurovascular Research and Journal of the Israeli Neurological Association.Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Mink serves as an Associate Editor for Neurology®; serves as an editorial board member of Journal of Child Neurology and Pediatric Neurology; serves on the scientific advisory board for Edison Pharmaceuticals Inc. and Data and Safety Monitoring Board; and receives research support from the NIH.

1) Advanced neurologic disease applications and 2) Topic of the month: Child neurology topics. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Robert Holloway about his paper on advanced neurologic disease. Dr. Chafic Karam is reading our e-Pearl of the week about exploding head syndrome. In the next part of the podcast Dr. Jeff Waugh interviews Dr. Blaise Bourgeois about the topic of pediatric epilepsy. The participants had nothing to disclose except Drs. Burns, Holloway, Karam and Bourgeois.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Holloway serves as an Associate Editor of Neurology Today; is a consultant for Milliman Guidelines Inc.; and receives research support from the NIH.Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bourgeois served as a one-time consultant to Upsher-Smith Laboratories, Inc.; serves on the Data and Safety Monitoring Board for Pfizer Inc; receives research support from Lundbeck Inc.; receives royalties from the publication of Pediatric Epilepsy, 3d Edition and The Epilepsy Prescriber's Guide to Antiepileptic Drugs and one of several people holding a patent on technology that allows patient-specific early seizure detection based on EEG recording in patients with epileptic seizures.

1) AAN paper on teleneurology applications and 2) Topic of the month: Child neurology topics. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Nina Solenski interviews Dr. Lawrence Wechsler about this AAN paper on teleneurology applications. Dr. Chafic Karam is reading our e-Pearl of the week about tactile mitgehen. In the next part of the podcast Dr. Jeff Waugh interviews Dr. Gabrielle deVeber about the topic of pediatric stroke. The participants had nothing to disclose except Drs. Wechsler and Karam.Dr. Wechsler serves on the scientific advisory boards for Lundbeck Inc., Neurointerventions Therapeutics, Inc and Silk Road Medical, Inc; receives research support from the NIH (for patient clinical trials), provides telestroke services to hospitals in Pennsylvania and Maryland; holds stock options in Neurointerventions Therapeutics, Inc.Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section.

1) Depression in epilepsy and 2) Topic of the month: Child neurology topics. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Chenjie Xia interviews Ms. Kirsten Fiest about her paper on depression in epilepsy. Dr. Chafic Karam is reading our e-Pearl of the week about the art of memory revisited. In the next part of the podcast Dr. Jeff Waugh interviews Dr. Mark Gorman about the topic of autoimmune disorders. The participants had nothing to disclose except Dr. Karam.Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section.

Topics in biostatistics

1) Prolonged anoxic vegetative state and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Flaherty interviews Prof. Luigi Trojano and Dr. Anna Estraneo about their paper on prolonged anoxic vegetative state. Dr. Jen Fugate is reading our e-Pearl of the week about myokymia. In the next part of the podcast Dr. Mike Sowell interviews Dr. Beau Bruce about the topic of pseudotumor cerebri. The participants had nothing to disclose except Drs. Flaherty, Fugate, Bruce and Prof. Trojano.Dr. Flahery serves on the scientific advisory board for CSL Behring; is a consultant for CSL Behring; has a patent pending for non-invasive CNS monitor; receives research support from the NIH and the Principal Investigator of a phase II NINDS-funded trial (STOP-IT) with study drug supplied by Novo Nordisk.Prof. Trojano receives royalties from the publication of the books Neuropsicologia dei Lobi Frontali. Sindrome disesecutive e disturbi del comportamento and Lineamenti di Neuropsicologia Clinica.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce is a consultant for Kaiser Permanente of Georgia; receives research support from Teva Pharmaceutical Industries Ltd., Pfizer Inc, and NIH; was a recipient of the Practice Research Fellowship.

1) Unresponsive wakefulness syndrome and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Thos Cochrane interviews Dr. Boris Kotchoubey about his paper on unresponsive wakefulness syndrome. Dr. Jen Fugate is reading our e-Pearl of the week about periodic alternating nystagmus. In the next part of the podcast Dr. Mike Sowell interviews Dr. Andrew Hershey about the topic of pediatric headache. The participants had nothing to disclose except Drs. Cochrane, Kotchovsky, Fugate and Hershey.Dr. Cochrane receives royalties from the publication of the book First Aid for the Boards: Neurology.Dr. Kotchoubey receives research support from Deutsche Forschungsgemeinschaft.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Hershey serves as an Associate Editor for Headache and Cephalagia; serves on the scientific advisory boards for MAP Pharmaceuticals, Inc., GlaxoSmithKline, Allergan, Inc. and Impax Laboratories, Inc..

1) Incident Parkinson disease and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Tien Khoo about his paper on incident Parkinson disease. Dr. Jen Fugate is reading our e-Pearl of the week about paroxysmal dysarthria and ataxia. In the next part of the podcast Dr. Mike Sowell interviews Dr. Alan Finkel about the topic of post-traumatic headache. The participants had nothing to disclose except Drs. Morgan, Khoo, Fugate and Finkel.Dr. Morgan has served on the speakers' bureau of GE Healthcare, GlaxoSmithKline, Teva Pharmaceuticals Industries Ltd., and UCB Pharma; has performed CME for Oakstone Publishing, LLC; is a consultant for Veloxis Pharmaceuticals, Chelsea Therapeutics, and Impax Laboratories, Inc.; receives research support from NIH as a sub-investigator and received compensation for review of medical records and expert witness testimony in multiple cases of litigation involving neurological conditions.Dr. Khoo receives speaker honoraria from Teva and Lundbeck; receives funding for travel from GlaxoSmithKline and receives educational support from a grant with UCB Pharma.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Finkel serves on the speakers' bureau of Allergan, Inc. receives research support from American Headache Society, DVBIC and the American Academy of Neurology.

1) Pre-hospital thrombolysis and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joachim Weber about his paper on pre-hosptial thrombolysis. Dr. Jen Fugate is reading our e-Pearl of the week about Ondine's curse. In the next part of the podcast Dr. Jen Bickel interviews Dr. Todd Rozen about the topic of cluster headaches. The participants had nothing to disclose except Drs. Audebert and Fugate.Dr. Audebert serves as Associate Editor for Frontiers of Teleneurology; is a consultant for Lundbeck Inc.; receives speaker honoraria from Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, Lundbeck Inc., Bayer Vital, UCB, Sanofi-Syntelabo Inc and Pfizer Inc; receives research support from Center for Stroke Research Berlin funded by the German Federal Ministry of Education and Research and funding of the STEMO project by the Technology Foundation Berlin with co-financing by the European Union; serves on the speakers' bureau of German TeleStroke Networks within the Competence Network Stroke and gave expert testimony in a trial launched by Lundbeck Inc. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section.

Polyneuropathy

1) Active multiple sclerosis and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Johansen interviews Dr. Jack Ratchford about his paper on active multiple sclerosis. Dr. Jen Fugate is reading our e-Pearl of the week about nummular headache. In the next part of the podcast Dr. Jen Bickel interviews Dr. Gretchen Tietjen about the topic of women and migraine. The participants had nothing to disclose except Drs. Ratchford, Fugate and Tietjen.Dr. Ratchford serves as a consultant for Biogen Idec, Bristol-Myers Squibb and Diogenix, Inc.; and receives research support from Biogen Idec, Novartis, and Sun Pharmaceuticals. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Tietjen serves as an Associate Editor of Headache; serves on the scientific advisory board for MAP Pharmaceuticals Inc. and holds stock options in Johnson & Johnson and Stryker.

1) Multiple cranial nerve impairment and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Stephen Donahue interviews Dr. Vincent Roubeau about his paper on multiple cranial nerve impairment. Dr. Chafic Karam is reading our e-Pearl of the week about neurosyphilis presenting as mesial temporal encephalitis. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about vitamin deficiency, infection and autoimmunity. The participants had nothing to disclose except Drs. Karam, Burns, Lewis and Weathers.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.

1) Orexin receptor antagonism and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Drs. Tom Roth and Joe Herring about their paper on orexin receptor antagonism for treatment of insomnia.Dr. Chafic Karam is reading our e-Pearl of the week about central fourth nerve palsies. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about drugs that can cause encephalopathy. All participants have disclosures.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Roth serves on the scientific advisory boards for Merck, Jazz and Transcept; serves as an editorial board member for Sleep and Sleep Medicine; receives research support from Transcept Pharmaceuticals, Impax Pharmaceuticals, Linguflex LLC and APnes, serves on the speakers' bureau of Purdue Pharma L.P. and is a consultant for Abbott Laboratories, Accadia, Acogolix Inc., Acorda, Actelion Pharmaceuticals Ltd, Addrenex Pharmaceuticals, Inc, Alchemers, Alza Corporation, Ancel, Arena, AstraZeneca, Aventis, AVER, Bayer Schering Pharma, BMS, BTG, Cephalon, Inc., Cypress, Dove, Eisai Inc., Elan Corporation, Eli Lilly and Company, Evotec, Forest Laboratories, Inc., GlaxoSmithKline, Hypnion Inc, Impax Pharmaceuticals, Intec, Intra-Cellular Therapies, Jazz, Johnson & Johnson, King Pharmaceuticals, Lundbeck, Inc., McNeil, MediciNova, Merck, Neurim Pharmaceuticals Ltd, Neurocrine, Neurogen, Novartis, Orexo, Organon Pharmaceuticals, Otsuka Pharmaceuticals, Inc., Prestwick, Proctor & Gamble Pharmaceuticals, Pfizer Inc, Purdue Pharma L.P., Resteva, Roche, Sanofi-aventis, Schoering-Plough Corp., Sepracor Inc., Servier Laboratories, Shire plc, Somaxon Pharmaceuticals, Syrex, Takeda Pharmaceutical Company Limited, TransOral, Yanda, VivoMetrics Inc, Wyeth, Yamanuchi Pharmaceutical, and XenoPort.Dr. Herring is Executive Director, Clinical Neuroscience at Merck; receives research support as an employee at Merck and holds stock options with Merck.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.

Neuro-Opthamology Topics

1) Bell's palsy and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Elliot Dimberg interviews Dr. Gary Gronseth about the guideline update on Bell's palsy. Dr. Stacey Clardy is reading our e-Pearl of the week about catathrenia (sleep related groaning). In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about encephalopathy caused by other organ failure. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Gronseth, Clardy, Burns, Lewis and Weathers.Dr. Gronseth serves on the editorial board of Neurology Now; received speakers' fees from Boehringer Ingelheim (resigned December 2011) and receives research support from the American Academy of Neurology.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.

1) Paroxysmal dyskinesia and hemiplegic migraine and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Waugh interviews Drs. Renzo Guerrini and Alice Gardiner about their papers on paroxysmal dyskinesia and hemiplegic migraine. Dr. Stacey Clardy is reading our e-Pearl of the week about plus-minus lid syndrome. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about encephalopathy caused by liver and kidney dysfunction. The participants had nothing to disclose except Drs. Waugh, Guerrini, Gardiner, Clardy, Burns, Lewis and Weathers.Dr. Waugh serves on the editorial board of the Journal of Pediatric Biochemistry.Dr. Guerrini serves as an Associate Editor for Epilepsia, serves on the editorial boards for Seizure, BMC Medical Genetics, Topics in Epilepsy, Journal of Pediatric Epilepsy, Epileptic Disorders and European Neurological Journal, serves on the International Advisory Board for Progress in Epileptic Disorders; has received honoraria from Biocodex, UCB, Eisai Inc, ValueBox, Viropharma and EMA (European Medicine Agency), received funding for travel from Japanese Epilepsy Society and Weill Cornell Medical College; receives research support from the Italian Ministry of Health, the European Community Sixth Framework Thematic Priority Life Sciences, Genomics and Biotechnology for Health, the Italian Ministry of Education, University and Research, the Tuscany Region, the Telethon Foundation, and the Mariani Foundation; receives royalties for the books: Epilepsy and Movement disorders, Aicardi's Epilepsy in children, Progress in epileptic spasms and West syndrome, Epilepsy and migraine, The causes of epilepsy and Dravet syndrome.Dr. Gardiner receives research support from The Muscular Dystrophy Campaign.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.

1) Parkinson disease and driving and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Alex Crizzle about his paper on Parkinson disease and driving. Dr. Stacey Clardy is reading our e-Pearl of the week about tumarkin attacks-the otolithic catastrophe. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about electrolytes and other metabolic disorders. The participants had nothing to disclose except Drs. Morgan, Crizzle, Clardy, Burns, Lewis and Weathers.Dr. Morgan has served as a consultant or received speaking honoraria for work with Chelsea Therapeutics, GlaxoSmithKline, Oakstone, Teva Pharmaceuticals, UCB Pharma, GE Healthcare, Impax Laboratories and Veloxis; has received compensation for review of medical records and expert witness testimony in multiple cases of litigation involving neurologic conditions and his clinical group receives funding from the National Parkinson Foundation as a Center of Excellence. Dr. Crizzle receives research support from the National Parkinson's Foundation.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.

1) Neurodegenerative causes of death and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Kutcher interviews Dr. Everett Lehman about his paper on National Football League players. Dr. Stacey Clardy is reading our e-Pearl of the week about the palmonental reflex: Beyond the pain. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about encephalopathies caused by endocrine disorders. All participants have disclosures.Dr. Kutcher is a consultant for the National Hockey League Players' Association and receives research support from ElMindA, Ltd..Dr. Lehman serves as an editorial board member for Public Health Reports and is Deputy Division Director for the Centers for Disease Control and Prevention (U. S. Federal government).Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.

Limb Apraxias

1) Intracranial arterial stenosis and 2) Topic of the month: Evaluation of polyneuropathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brad Worrall with Drs. Xunming Ji and Ran Meng about their paper on intracranial arterial stenosis. Dr. Jennifer Fugate is reading our e-Pearl of the week about Kleine-Levin syndrome. In the next part of the podcast Dr. Ted Burns interviews Dr. Peter James Dyck about evaluation of demyelinating polyneuropathy. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Worrall, Fugate, Burns, and Dyck.Dr. Worrall has received research funding from NIH (6 grants). He serves as an outcomes adjudicator for the NHLBI for AREDS2 and as an ad hoc reviewer for the NIH and Veterans Administration study sections. Dr. Worrall received several honoraria for serving as faculty and/or director for courses at the AAN annual meetings and an honorarium for speaking for the Operation Stroke program (AHA/ASA funded) at Fairfax Inova Hospital. Dr. Worrall is on the Editorial Boards of Neurology and Seminars in Neurology. Dr. Worrall received nominal royalties for serving as a Chapter Author for Merritt's Neurology and receives an honorarium as Associate Editor of Neurology. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Ted Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Dyck serves as an Associate Editor of Diabetes; is employed as a consultant in Neurology at the Mayo Clinic and receives research support from Pfizer Inc, Isis Pharmaceuticals, Inc., Anylam Pharmaceuticals and the NIH.

1) Early epileptiform abnormalities and 2) Topic of the month: Evaluation of polyneuropathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Quigg with Drs. Moushin Shafi and Brandon Westover about their paper on absence of early epileptiform abnormalities. Dr. Jennifer Fugate is reading our e-Pearl of the week about Doral midbrain syndrome. In the next part of the podcast Dr. Ted Burns interviews Drs. Michelle L. Mauermann and P. James Dyck about evaluation of the chronic, axonal polyneuropathy. The participants had nothing to disclose except Drs. Quigg, Shafi, Fugate, Burns and Mauermann.Dr. Quigg receives royalties from the publication of the book EEG Pearls; has a patent for actigraphy system for seizure characterization and receives research support from the NIH.Dr. Shafi performs EMG and cEEG monitoring studies in his epilepsy practice (35% effort); receives honoraria from (1) J. Kiffin Penry Epilepsy Minifellowship - reimbursement for travel, conference accommodations and food (2) American Epilepsy Society Fellows Program - funds for travel and attendance at 2011 American Epilepsy Society conference; and receives research support from (1) National Center for Research Resources: Harvard Clinical and Translational Science Center and the Center for Integration of Medicine and Innovative Technology and is funded by the NIH. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Ted Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Mauermann receives research support from Pfizer Inc and the NIH.

1) ALS studies and 2) Topic of the month: Evaluation of polyneuropathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns with Dr. Michael Benatar about his paper on studies in ALS. Dr. Jennifer Fugate is reading our e-Pearl of the week about Gradenigo syndrome. In the next part of the podcast Dr. Ted Burns interviews Drs. Michelle L. Mauermann and P. James Dyck about evaluation of polyneuropathy, basics. The participants had nothing to disclose except Drs. Burns, Benatar, Fugate and Mauermann.Dr. Ted Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Benatar serves as an editorial board member for Journal Watch Neurology; serves on the scientific advisory board for Cytokinetics; is a consultant for Cytokinetics and Asubio Pharmaceuticals Inc.; receives royalties from the publication of the books (1) Neuromuscular Disease: Evidence and Analysis in Clinical Neurology, (2) BluePrints in Neurology, (3) Field of Vision; receives travel funding from the (1) American Academy of Neurology, (2) Myasthenia Gravis Foundation of America; receives research support from the CytRx Corporation, Food and Drug Administration, Muscular Dystrophy Association, ALS Association, Woodruff Foundation and the NIH; involved in legal proceedings with Sutter, O'Connel and Farchione Attorneys as well as Parker Waichmann LLP. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Mauermann receives research support from Pfizer Inc and the NIH.

1) Indicators of amyloid burden and 2) Topic of the month: Evaluation of polyneuropathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns with Dr. Michelle M. Mielke about her paper on indicators of amyloid burden. Dr. Jennifer Fugate is reading our e-Pearl of the week about vestibular migraine. In the next part of the podcast Dr. Ted Burns interviews Dr. Michael Shy about evaluation of the inherited neuropathy patient. The participants had nothing to disclose except Drs. Jeff Burns, Mielke, Fugate, Ted Burns and Shy.Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International, Johnson County Clinical trials; receives speakers' fees from Novartis Pharmaceuticals Ltd; and receives research support from the NIH, Elan, Janssen Pharmaceuticals Inc., Pfizer Inc, Novartis Pharmaceuticals Ltd and Danone.Dr. Mielke has received research support from the Cynthia and George Mitchell Foundation, Walter S. and Lucienne B. Driskill Foundation and the NIH.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Ted Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Shy serves as an editorial board member of Journal of Peripheral Nerve System; receives research support from Muscular Dystrophy Association, Charcot Marie Tooth Association and the NIH.

1) Orthostatic intolerance and 2) Topic of the month: Evaluation of polyneuropathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns with Dr. Paola Sandroni about her paper on orthostatic intolerance. Dr. Jennifer Fugate is reading our e-Pearl of the week about bright tongue sign. In the next part of the podcast Dr. Ted Burns interviews Dr. Vera Bril about symptomatic treatment of painful diabetic neuropathy. The participants had nothing to disclose except Drs. Burns, Sandroni, Fugate and Bril.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Sandroni receives research funding from the NIH.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bril received speakers' fees from Pfizer Inc and for a talk last year for European Federation of Neurological Societies and received research funding from Talecris Biotherapeutics, Inc..

Diagnosis of Alzheimer's and MCI

1) Vitamin D, cognition and dementia and 2) Topic of the month: Bedside Neuro-ophthalmology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns with Dr. Cynthia Balion about her paper on vitamin D, cognition and dementia. Dr. Stacy Clardy is reading our e-Pearl of the week about single-shot fast spin echo. In the next part of the podcast Dr. Beau Bruce focuses his interview with Dr. Kathleen Digre about direct ophthalmoscopy tips. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Burns, Balion, Clardy, Bruce and Digre.Dr. Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International, Johnson County Clinical trials; receives speakers' fees from Novartis Pharmaceuticals Ltd; and receives research support from the NIH, Elan, Janssen Pharmaceuticals Inc., Pfizer Inc, Novartis Pharmaceuticals Ltd and Danone.Dr. Balion receives research support from the Agency for Healthcare Research and Quality, Canada Foundation for Innovation, Ontario Ministry of Health and Long-Term Care and Canadian Institutes of Health Research.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce received research funding from the NIH.Dr. Digre serves on the editorial board for Journal of Neuro-ophthlamology and Headache Currents; receives research support from Pfizer, Anterior Ischemic Optic Neuropathy: possible trigger factors related to the development of AION and NEI: Idiopathic Intracranial Hypertension Treatment Trial.

1) Neuromyelitis optica phenotype and 2) Topic of the month: Bedside Neuro-ophthalmology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Nick Johnson with Dr. Jacqueline Palace about her paper on neuromyelitis optica phenotype. Dr. Stacey Clardy is reading our e-Pearl of the week about Duret hemorrhage. In the next part of the podcast Dr. Beau Bruce interviews Dr. Jonathan Trobe about bedside visual field examination. The participants had nothing to disclose except Drs. Palace, Clardy, and Bruce.Dr Palace serves on the scientific advisory board for Charcot Foundation, Biogen Idec, Merck Serono Ltd, Bayer Schering Pharma, Novartis Pharmaceuticals Uk Ltd, Teva Pharmaceutical Industries Ltd.; receives research support from the National MS Society, QIDIS, Oxford Health Services Research Committee, John Fell Research Fund, Merck Serono Ltd. and Bayer Schering Pharma and conference expenses from Novartis and Merck Serono Ltd. Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce received research funding from the NIH.

1) Epilepsy surgery and 2) Topic of the month: Bedside Neuro-ophthalmology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Jen with Dr. Nathalie Jette about her paper on an outline tool to determine epilepsy surgery. Dr. Stacey Clardy is reading our e-Pearl of the week about gelastic seizures. In the next part of the podcast Dr. Beau Bruce interviews Dr. Randy Kardon about "big pupil" consult. All participants have disclosures.Dr. Jen serves as Section Editor for Experimental Brain Research, Cellular and Molecular Neurobiology and Associate Editor for Frontiers in Neuro-otology and is funded by the FDA and NIH. Dr. Jette serves on the editorial board for Epilepsia, is the holder of a Canada Research Chair in Neuroscience Health Services Research and receives research support from: Alberta Health and Wellness, Public Health Agency of Canada, Canadian Institutes of Health Research, Alberta Innovates Health Solutions, University of Calgary and Alberta Health Services.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce received research funding from the NIH.Dr. Kardon serves on the editorial board for Journal of Neuro-ophthalmology and Archives of Ophthalmology; has patents for method of characterizing focal pupil responses to light and method of assessing retinal function using infrared optical signals in response to light; receives royalties for the publication of Tissues and Organs: A text-atlas of scanning electron microscopy and for use of micrographs in other textbooks; is a consultant for Novartis Pharmaceuticals Ltd; receives research support from the Department of Veterans Affairs Iowa City Center of Excellence for the Prevention and Treatment of Visual Loss, Department of Defense Vision Research Program (TATRC) and Department of Veterans Affairs Rehabilitation Division.

1) C90RF72 mutations and 2) Topic of the month: Bedside Neuro-ophthalmology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns with Drs. Sharon Sha and Carol Dobson-Stone about their papers on frontotemporal dementia. Dr. Stacey Clardy is reading our e-Pearl of the week about Hanes sign. In the next part of the podcast Dr. Beau Bruce interviews Dr. Randy Kardon about relative afferent papillary defect. Dr. Bruce will interview Dr. Kardon next week about "big pupil" consult. The participants had nothing to disclose except Drs. Burns, Dobson-Stone, Clardy, Bruce and Kardon.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Dobson-Stone receives research funding from the National Health and Medical Research Council (Australia).Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce received research funding from the NIH.Dr. Kardon serves on the editorial board for Journal of Neuro-ophthalmology and Archives of Ophthalmology; has patents for method of characterizing focal pupil responses to light and method of assessing retinal function using infrared optical signals in response to light; receives royalties for the publication of Tissues and Organs: A text-atlas of scanning electron microscopy and for use of micrographs in other textbooks; is a consultant for Novartis Pharmaceuticals Ltd; receives research support from the Department of Veterans Affairs Iowa City Center of Excellence for the Prevention and Treatment of Visual Loss, Department of Defense Vision Research Program (TATRC) and Department of Veterans Affairs Rehabilitation Division.

Interviews with Dean Buonomono on memory function

1) Reportable neurologic disorders and 2) Topic of the month: Apraxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Shanna Patterson interviews Dr. Farrah Mateen about her paper on reportable neurologic disorders in refugee camps. Dr. Chafic Karam is reading our e-Pearl of the week about sporadic amyotrophic lateral sclerosis. In the next part of the podcast Dr. Ted Burns focuses his interview with Dr. Ken Heilman about some of the neurologic diseases that cause apraxia. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Karam, Burns and Heilman.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Heilman serves as an editorial board member for ACTA Neuropsychologia, The Journal of Contemporary Neurology, Journal of the International Neuropsychological, Neurocase, Neuropsychiatry, Neuropsychology and Behavioral Neurology-Cognitive and Behavioral Neurology, Brain and Cognition, Journal of Neuropsychology and Journal of Clinical Neurology; receives royalties for the publication of Clinical Neuropsychology, fifth edition, PGY1: Lessons in Caring, Neurological Therapeutics : Principles and Practice second edition, Creativity and the Brain, Clinical Neuropsychology, fourth edition, Neurological Therapeutics : Principles and Practice, The Matter of Mind, A Neurologist's View of Brain Behavior Relationships, Apraxia, Helping People with Memory Disorders: A Guide for You and Your Family, Clinical Neuropsychology, third edition, Clinical Neuropsychology, second edition, Neuropsychology of Human Emotion, Clinical Neuropsychology and The Differential Diagnosis of Neurological Diseases; and receives funding from current (active) funded research proposals, Alzheimer's Disease Initiative State of Florida, Dept. of Elder Affairs, Memory Disorder Clinics, and the NIH.

1) Adult neurology training and 2) Topic of the month: Apraxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Goodkin interviews Dr. Nina Schor about her paper on adult neurology training during child neurology residency. Dr. Chafic Karam is reading our e-Pearl of the week about transthyretin amyloidosis. In the next part of the podcast Dr. Ted Burns interviews Dr. Ken Heilman about dissociation and conceptual apraxia. The participants had nothing to disclose except Drs. Goodkin, Schor, Karam, Burns and Heilman.Dr. Goodkin serves on the scientific board for Tuberous Sclerosis Alliance and CURE; serves on the editorial board for Neurology and Surgical Neurology International; received royalties for an entry in Up-to-date entitled: The choking game and other strangulation activities in children and adolescents and is funded by NIH grants.Dr. Schor serves as an editorial board member for MedLink Neurology, Neurology, Pediatric Neurology and Journal of Child Neurology; receives royalties for the publication of Nelson's Textbook of Pediatrics and Swaiman's Pediatric Neurology: Principles and Practice and is funded by the NIH.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Heilman serves as an editorial board member for ACTA Neuropsychologia, The Journal of Contemporary Neurology, Journal of the International Neuropsychological, Neurocase, Neuropsychiatry, Neuropsychology and Behavioral Neurology-Cognitive and Behavioral Neurology, Brain and Cognition, Journal of Neuropsychology and Journal of Clinical Neurology; receives royalties for the publication of Clinical Neuropsychology, fifth edition, PGY1: Lessons in Caring, Neurological Therapeutics : Principles and Practice second edition, Creativity and the Brain, Clinical Neuropsychology, fourth edition, Neurological Therapeutics : Principles and Practice, The Matter of Mind, A Neurologist's View of Brain Behavior Relationships, Apraxia, Helping People with Memory Disorders: A Guide for You and Your Family, Clinical Neuropsychology, third edition, Clinical Neuropsychology, second edition, Neuropsychology of Human Emotion, Clinical Neuropsychology and The Differential Diagnosis of Neurological Diseases; and receives funding from current (active) funded research proposals, Alzheimer's Disease Initiative State of Florida, Dept. of Elder Affairs, Memory Disorder Clinics, and the NIH.

1) Antiplatelets versus anticoagulation and 2) Topic of the month: Apraxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Hugh Markus about his paper on antiplatelets versus anticoagulation for dissection. Dr. Chafic Karam is reading our e-Pearl of the week about caffeine and Parkinson disease. In the next part of the podcast Dr. Ted Burns interviews Dr. Ken Heilman about limb-kinetic, ideomotor and ideational apraxias and how it might come to our attention. The participants had nothing to disclose except Drs. Markus, Karam, Burns and Heilman.Dr. Markus has served on scientific advisory boards for W. L. Gore & Associates, Inc., Boehringer Ingelheim, and Sanofi-Synthélabo; serves on the editorial boards of Stroke and Clinical Neurology and Neurosurgery; receives publishing royalties for Stroke Medicine (Oxford University Press, 2010); served as a consultant for Archimex SAS and Shire plc; and has received research support from Archimex SAS, Shire plc, MRC UK, the Stroke Association, the European Union, Wellcome Trust and the British heart Foundation.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Heilman serves as an editorial board member for ACTA Neuropsychologia, The Journal of Contemporary Neurology, Journal of the International Neuropsychological, Neurocase, Neuropsychiatry, Neuropsychology and Behavioral Neurology-Cognitive and Behavioral Neurology, Brain and Cognition, Journal of Neuropsychology and Journal of Clinical Neurology; receives royalties for the publication of Clinical Neuropsychology, fifth edition, PGY1: Lessons in Caring, Neurological Therapeutics : Principles and Practice second edition, Creativity and the Brain, Clinical Neuropsychology, fourth edition, Neurological Therapeutics : Principles and Practice, The Matter of Mind, A Neurologist's View of Brain Behavior Relationships, Apraxia, Helping People with Memory Disorders: A Guide for You and Your Family, Clinical Neuropsychology, third edition, Clinical Neuropsychology, second edition, Neuropsychology of Human Emotion, Clinical Neuropsychology and The Differential Diagnosis of Neurological Diseases; and receives funding from current (active) funded research proposals, Alzheimer's Disease Initiative State of Florida, Dept. of Elder Affairs, Memory Disorder Clinics, and the NIH.

1) Creutzfeldt-Jakob disease and 2) Topic of the month: Apraxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Clive Hamlin about his paper on diagnosis of Creutzfeldt-Jakob disease. Dr. Chafic Karam is reading our e-Pearl of the week about POEMS syndrome. In the next part of the podcast Dr. Ted Burns interviews Dr. Ken Heilman about definitions for apraxia and various forms of apraxia. Dr. Burns will interview Dr. Heilman about other forms of apraxias over the next three weeks. The participants had nothing to disclose except Drs. Burns, Karam, and Heilman.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Heilman serves as an editorial board member for ACTA Neuropsychologia, The Journal of Contemporary Neurology, Journal of the International Neuropsychological, Neurocase, Neuropsychiatry, Neuropsychology and Behavioral Neurology-Cognitive and Behavioral Neurology, Brain and Cognition, Journal of Neuropsychology and Journal of Clinical Neurology; receives royalties for the publication of Clinical Neuropsychology, fifth edition, PGY1: Lessons in Caring, Neurological Therapeutics : Principles and Practice second edition, Creativity and the Brain, Clinical Neuropsychology, fourth edition, Neurological Therapeutics : Principles and Practice, The Matter of Mind, A Neurologist's View of Brain Behavior Relationships, Apraxia, Helping People with Memory Disorders: A Guide for You and Your Family, Clinical Neuropsychology, third edition, Clinical Neuropsychology, second edition, Neuropsychology of Human Emotion, Clinical Neuropsychology and The Differential Diagnosis of Neurological Diseases; and receives funding from current (active) funded research proposals, Alzheimer's Disease Initiative State of Florida, Dept. of Elder Affairs, Memory Disorder Clinics, and the NIH.

In this special podcast for the Neurology Journal, Dr. Ted M. Burns plays a dozen of the many interesting audio clips from Neurology Podcasts of the 2011-2012 academic year.

1) Prevention of new brain lesions and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Pearce Korb interviews Dr. David Mohr about his paper on stress management for the prevention of new brain lesions. Dr. Jennifer Fugate is reading our e-Pearl of the week about Panayiotopoulos syndrome. In the next part of the podcast Dr. Alberto Espay interviews Dr. Chris Austin about his plenary session on translational therapeutics development at NIH. The participants had nothing to disclose except Drs. Mohr, Fugate, and Espay.Dr. Mohr is a consultant for the NIH and receives research support from NIH.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay is supported by the K23 career development award (NIMH, 1K23MH092735); has received grant support from CleveMed/Great Lakes Neurotechnologies, Davis Phinney Foundation, and Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Solvay Pharmaceuticals, Inc., Abbott, Chelsea Therapeutics, TEVA Pharmaceutical Industries Ltd, Impax Pharmaceuticals, Solstice Neurosciences, and Eli Lilly and Company; and honoraria from Novartis, the American Academy of Neurology, and the Movement Disorders Society. He serves as Assistant Editor of Movement Disorders and on the editorial boards of The European Neurological Journal and Frontiers in Movement Disorders.